Showing 2611-2620 of 5771 results for "".
- Envision Research Institute Announces Search for Post Doctoral Fellows to Study Low Visionhttps://modernod.com/news/envision-research-institute-announces-search-for-post-doctoral-fellows-to-study-low-vision/2479664/The Gigi & Carl Allen Envision Research Institute (ERI) is now calling for letters of intent to apply for its next round of postdoctoral research fellowships. Launched in 2015 with a goal to restore function to those who are blind and visually impaired, the ERI provides access to funds, facil
- Second Sight Announces Final 2019 Medicare Hospital Outpatient Payment Rate for the Argus II Retinal Prosthesis Systemhttps://modernod.com/news/second-sight-announces-final-2019-medicare-hospital-outpatient-payment-rate-for-the-argus-ii-retinal-prosthesis-system/2479688/Second Sight Medical Products
- Oculus Announces New Joystick for the Keratograph 5M With Release Functionhttps://modernod.com/news/oculus-announces-new-joystick-for-the-keratograph-5m-with-release-function/2479779/As of September 2018, the Oculus Keratograph 5M comes equipped with a new joystick including a release function. This enables the user to capture images and video sequences with the simple push of a button on the devi
- Topcon Announces Appointment of Gregory Hoffmeyer to Director of OCT Clinical Saleshttps://modernod.com/news/topcon-announces-appointment-of-gregory-hoffmeyer-to-director-of-oct-clinical-sales/2479902/Gregory Hoffmeyer has joined the Topcon sales team as director of OCT clinical sales. Mr. Hoffmeyer will be reporting to Corey Nielson, vice president of sales. Mr. Hoffmeyer previously worked as the senior cli
- Astellas Announces Acquisition of Quethera, Maker of Gene Therapy Program for Glaucomahttps://modernod.com/news/astellas-announces-acquisition-of-quethera-maker-of-gene-therapy-program-for-glaucoma/2479949/Astellas Pharma has acquired Quethera, a gene therapy company headquartered in the United Kingdom that is focused on developing novel treatments for ocular disorders, such as glaucoma. Under the terms of the agreement, Astellas may pay up to £85 million ($1
- Topcon Announces Release of Augmented Reality (AR) Apphttps://modernod.com/news/topcon-announces-release-of-augmented-reality-ar-app/2479991/Topcon Medical Systems has nnounce the release of the Topcon Augmented Reality (AR) App. The Topcon AR App makes use of augmented
- Aerie Pharmaceuticals Announces Early Notification of FDA Acceptance of NDA Submission for Roclatanhttps://modernod.com/news/aerie-pharmaceuticals-announces-early-notification-of-fda-acceptance-of-nda-submission-for-roclatan/2479999/Aerie Pharmaceuticals reported that it has received the “Day 74” notification from the FDA earlier than scheduled. The FDA has completed its initial 60-day review of the new drug application (NDA) for Roclatan (netarsudil/latanoprostnetarsudil ophthalmic solution) 0.02%/0.005% and the FDA has det
- LensGen Announces Funding And Patent Successhttps://modernod.com/news/lensgen-announces-funding-and-patent-success/2480017/LensGen, a private California company developing the world’s first modular, fluid-optic, curvature changing IOL, is reporting significant progress in its effort to transform how presbyopia is addressed, according to a company news release. The company successfully achieved a key clin
- American Academy of Optometry Announces 2018 Award Recipientshttps://modernod.com/news/american-academy-of-optometry-announces-2018-award-recipients/2480026/Each year the American Academy of Optometry recognizes distinguished individuals who have made countless important contributions to advancing the profession of optometry. “Every nominee represents exactly what the American Academy
- Association of Optometrists and SECO International Announce Partnership with Armed Forces Optometric Society for Therapeutics London 2018https://modernod.com/news/association-of-optometrists-and-seco-international-announce-partnership-with-armed-forces-optometric-society-for-therapeutics-london-2018/2480047/The Association of Optometrists (AOP) and SECO International have partnered with the Armed Forces Optometric Society (AFOS) to present “Therapeutics London 2018,” an optometric continuing education and training (CET) conference focusing on therapeutics, being held September 23-24, 201